Search

Your search keyword '"Schwabl, Philipp"' showing total 614 results

Search Constraints

Start Over You searched for: Author "Schwabl, Philipp" Remove constraint Author: "Schwabl, Philipp"
614 results on '"Schwabl, Philipp"'

Search Results

4. Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome

5. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure

7. Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)

10. Genomics and spatial surveillance of Chagas disease and American visceral leishmaniasis

14. SAT-128 Circulating fibronectin levels are linked to endothelial dysfunction, fibrogenesis, and portal hypertension in advanced chronic liver disease

15. WED-089-YI Characterising the hemodynamic and pro-inflammatory profile of a CCl4/LPS-induced acute-on-chronic liver failure (ACLF) rat model

16. THU-540 Characterization of in vivo mouse models of regressive fibrosis and resolving portal hypertension

17. THU-071 Impact of underlying portal hypertension and systemic inflammation on acute-on-chronic liver failure (ACLF) severity and outcome

18. WED-125 Differential regulation of soluble guanylate cyclase signaling during liver fibrosis regression

19. Non-invasive tests for clinically significant portal hypertension after HCV cure

24. Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension

27. Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria

28. Contrasting genomic epidemiology between sympatricPlasmodium falciparumandPlasmodium vivaxpopulations

29. The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes

30. Placental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver disease

33. Temporal and spatial dynamics of Plasmodium falciparum clonal lineages in Guyana.

34. Temporal and spatial dynamics of Plasmodium falciparum clonal lineages in Guyana

35. Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosis

38. Colonization and genetic diversification processes of Leishmania infantum in the Americas

41. Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region

43. Resurgence of Vaccine-Preventable Diseases in Venezuela as a Regional Public Health Threat in the Americas

45. Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice

46. Diabetes impairs the haemodynamic response to non‐selective betablockers in compensated cirrhosis and predisposes to hepatic decompensation

47. Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol‐related cirrhosis

49. Clinical course of congestive hepatopathy pre/post heart transplantation

50. Systemic inflammation remains a critical determinant of the dynamic component of portal hypertension in abstinent patients with alcohol-related cirrhosis

Catalog

Books, media, physical & digital resources